Status:
UNKNOWN
Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients
Lead Sponsor:
Hasselt University
Conditions:
Covid-19
Eligibility:
All Genders
Brief Summary
The primary objective of the study is to evaluate cardiac and pulmonary hemodynamic changes over time as predictor of disease progression and outcome in COVID-19 patients admitted to ICU. The primary...
Detailed Description
Background COVID-19 can lead to a bilateral pneumonia overwhelming the lungs causing dyspnea and respiratory distress. Up to 20% of the infected population is hospitalized and 5% is submitted to the i...
Eligibility Criteria
Inclusion
- Patient admitted to ICU that is COVID-19 positive based on rt-PCR
- Ventilated or not ventilated
- No restrictions on age
- No restrictions on comorbidities or a diversity of underlying pathology (malignancies, COPD, …)
Exclusion
- Patients that are not COVID-19 tested (rt-PCR) or where the diagnosis is pending.
- Patients that refuse their participation in the study.
- Patients under legal protection, or deprived of their liberty.
- Patients that are so critically ill that a minimum of 1 follow-up is very unlikely to be realised
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04371679
Start Date
April 1 2020
End Date
December 1 2022
Last Update
March 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Hospital
Hasselt, Belgium, 3500